nodes	percent_of_prediction	percent_of_DWPC	metapath
Nisoldipine—CYP1A2—Dacarbazine—muscle cancer	0.0963	0.13	CbGbCtD
Nisoldipine—CYP3A7—Vincristine—muscle cancer	0.0921	0.124	CbGbCtD
Nisoldipine—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0921	0.124	CbGbCtD
Nisoldipine—ABCB1—Dactinomycin—muscle cancer	0.073	0.0983	CbGbCtD
Nisoldipine—CYP3A5—Vincristine—muscle cancer	0.0691	0.093	CbGbCtD
Nisoldipine—CYP3A5—Etoposide—muscle cancer	0.0633	0.0852	CbGbCtD
Nisoldipine—CACNA1S—pes—muscle cancer	0.0535	0.515	CbGeAlD
Nisoldipine—CYP1A2—Etoposide—muscle cancer	0.0471	0.0634	CbGbCtD
Nisoldipine—ABCB1—Vincristine—muscle cancer	0.045	0.0605	CbGbCtD
Nisoldipine—ABCB1—Etoposide—muscle cancer	0.0412	0.0555	CbGbCtD
Nisoldipine—ABCB1—Doxorubicin—muscle cancer	0.0281	0.0378	CbGbCtD
Nisoldipine—ABCB1—Methotrexate—muscle cancer	0.0272	0.0366	CbGbCtD
Nisoldipine—CYP3A4—Vincristine—muscle cancer	0.0269	0.0363	CbGbCtD
Nisoldipine—CYP3A4—Etoposide—muscle cancer	0.0247	0.0332	CbGbCtD
Nisoldipine—CYP3A4—Doxorubicin—muscle cancer	0.0168	0.0227	CbGbCtD
Nisoldipine—CACNA1S—tendon—muscle cancer	0.00409	0.0394	CbGeAlD
Nisoldipine—CACNB2—cardiac atrium—muscle cancer	0.00282	0.0272	CbGeAlD
Nisoldipine—CACNA1C—smooth muscle tissue—muscle cancer	0.00264	0.0254	CbGeAlD
Nisoldipine—CACNA1D—cardiac atrium—muscle cancer	0.00247	0.0238	CbGeAlD
Nisoldipine—CACNB2—tendon—muscle cancer	0.00246	0.0237	CbGeAlD
Nisoldipine—CACNA2D1—tendon—muscle cancer	0.00231	0.0223	CbGeAlD
Nisoldipine—CACNB2—vagina—muscle cancer	0.00228	0.022	CbGeAlD
Nisoldipine—CACNA1C—cardiac atrium—muscle cancer	0.00228	0.0219	CbGeAlD
Nisoldipine—CACNA2D1—bone marrow—muscle cancer	0.00224	0.0216	CbGeAlD
Nisoldipine—CACNA2D1—vagina—muscle cancer	0.00214	0.0207	CbGeAlD
Nisoldipine—CACNB2—head—muscle cancer	0.00211	0.0203	CbGeAlD
Nisoldipine—CACNB2—testis—muscle cancer	0.00204	0.0196	CbGeAlD
Nisoldipine—CACNA2D1—head—muscle cancer	0.00198	0.0191	CbGeAlD
Nisoldipine—CACNA2D1—testis—muscle cancer	0.00191	0.0184	CbGeAlD
Nisoldipine—CACNA1D—head—muscle cancer	0.00184	0.0178	CbGeAlD
Nisoldipine—CACNA1C—vagina—muscle cancer	0.00184	0.0177	CbGeAlD
Nisoldipine—CACNA1D—testis—muscle cancer	0.00178	0.0172	CbGeAlD
Nisoldipine—CACNA1C—head—muscle cancer	0.0017	0.0164	CbGeAlD
Nisoldipine—CACNA1C—testis—muscle cancer	0.00164	0.0158	CbGeAlD
Nisoldipine—CYP1A2—renal system—muscle cancer	0.0013	0.0125	CbGeAlD
Nisoldipine—CYP3A5—renal system—muscle cancer	0.00125	0.0121	CbGeAlD
Nisoldipine—CYP3A4—renal system—muscle cancer	0.000939	0.00904	CbGeAlD
Nisoldipine—CYP3A5—vagina—muscle cancer	0.000906	0.00873	CbGeAlD
Nisoldipine—Stomatitis—Vincristine—muscle cancer	0.000888	0.00581	CcSEcCtD
Nisoldipine—Amblyopia—Doxorubicin—muscle cancer	0.000886	0.00579	CcSEcCtD
Nisoldipine—Skin ulcer—Doxorubicin—muscle cancer	0.000879	0.00575	CcSEcCtD
Nisoldipine—Otitis media—Doxorubicin—muscle cancer	0.000879	0.00575	CcSEcCtD
Nisoldipine—ABCB1—embryo—muscle cancer	0.000878	0.00846	CbGeAlD
Nisoldipine—Skin discolouration—Methotrexate—muscle cancer	0.000875	0.00572	CcSEcCtD
Nisoldipine—Sweating—Vincristine—muscle cancer	0.000874	0.00571	CcSEcCtD
Nisoldipine—Rash pustular—Doxorubicin—muscle cancer	0.000858	0.00561	CcSEcCtD
Nisoldipine—Glossitis—Methotrexate—muscle cancer	0.000858	0.00561	CcSEcCtD
Nisoldipine—Herpes simplex—Methotrexate—muscle cancer	0.000858	0.00561	CcSEcCtD
Nisoldipine—Petechiae—Doxorubicin—muscle cancer	0.000832	0.00544	CcSEcCtD
Nisoldipine—Dysphagia—Etoposide—muscle cancer	0.000828	0.00541	CcSEcCtD
Nisoldipine—Chills—Dactinomycin—muscle cancer	0.000821	0.00537	CcSEcCtD
Nisoldipine—Hypoaesthesia—Vincristine—muscle cancer	0.000814	0.00532	CcSEcCtD
Nisoldipine—Alopecia—Dactinomycin—muscle cancer	0.000809	0.00529	CcSEcCtD
Nisoldipine—Vaginal inflammation—Methotrexate—muscle cancer	0.00079	0.00517	CcSEcCtD
Nisoldipine—Vasodilation procedure—Doxorubicin—muscle cancer	0.000779	0.00509	CcSEcCtD
Nisoldipine—Vasodilation—Doxorubicin—muscle cancer	0.000779	0.00509	CcSEcCtD
Nisoldipine—Melaena—Methotrexate—muscle cancer	0.000772	0.00505	CcSEcCtD
Nisoldipine—Skin discolouration—Doxorubicin—muscle cancer	0.000758	0.00495	CcSEcCtD
Nisoldipine—Ventricular extrasystoles—Doxorubicin—muscle cancer	0.000758	0.00495	CcSEcCtD
Nisoldipine—Cellulitis—Doxorubicin—muscle cancer	0.000753	0.00492	CcSEcCtD
Nisoldipine—Thinking abnormal—Doxorubicin—muscle cancer	0.000748	0.00489	CcSEcCtD
Nisoldipine—Cough increased—Doxorubicin—muscle cancer	0.000748	0.00489	CcSEcCtD
Nisoldipine—Vaginal infection—Methotrexate—muscle cancer	0.000746	0.00488	CcSEcCtD
Nisoldipine—Herpes simplex—Doxorubicin—muscle cancer	0.000743	0.00485	CcSEcCtD
Nisoldipine—Glossitis—Doxorubicin—muscle cancer	0.000743	0.00485	CcSEcCtD
Nisoldipine—Lacrimation increased—Doxorubicin—muscle cancer	0.000743	0.00485	CcSEcCtD
Nisoldipine—Ill-defined disorder—Dactinomycin—muscle cancer	0.000739	0.00483	CcSEcCtD
Nisoldipine—Nocturia—Doxorubicin—muscle cancer	0.000738	0.00482	CcSEcCtD
Nisoldipine—Anaemia—Dactinomycin—muscle cancer	0.000737	0.00482	CcSEcCtD
Nisoldipine—Acute coronary syndrome—Etoposide—muscle cancer	0.000728	0.00476	CcSEcCtD
Nisoldipine—Myocardial infarction—Etoposide—muscle cancer	0.000724	0.00473	CcSEcCtD
Nisoldipine—Alopecia—Vincristine—muscle cancer	0.000723	0.00473	CcSEcCtD
Nisoldipine—Stomatitis—Etoposide—muscle cancer	0.000719	0.0047	CcSEcCtD
Nisoldipine—Malaise—Dactinomycin—muscle cancer	0.000719	0.0047	CcSEcCtD
Nisoldipine—Mouth ulceration—Methotrexate—muscle cancer	0.000715	0.00467	CcSEcCtD
Nisoldipine—Ecchymosis—Methotrexate—muscle cancer	0.000715	0.00467	CcSEcCtD
Nisoldipine—Leukopenia—Dactinomycin—muscle cancer	0.000713	0.00466	CcSEcCtD
Nisoldipine—Gynaecomastia—Methotrexate—muscle cancer	0.000707	0.00462	CcSEcCtD
Nisoldipine—Vaginal inflammation—Doxorubicin—muscle cancer	0.000684	0.00447	CcSEcCtD
Nisoldipine—Myalgia—Dactinomycin—muscle cancer	0.000679	0.00444	CcSEcCtD
Nisoldipine—Abnormal dreams—Doxorubicin—muscle cancer	0.000676	0.00442	CcSEcCtD
Nisoldipine—Discomfort—Dactinomycin—muscle cancer	0.00067	0.00438	CcSEcCtD
Nisoldipine—Melaena—Doxorubicin—muscle cancer	0.000668	0.00437	CcSEcCtD
Nisoldipine—ABCB1—renal system—muscle cancer	0.000665	0.0064	CbGeAlD
Nisoldipine—Diabetes mellitus—Methotrexate—muscle cancer	0.00066	0.00431	CcSEcCtD
Nisoldipine—Hypoaesthesia—Etoposide—muscle cancer	0.000659	0.00431	CcSEcCtD
Nisoldipine—Anaemia—Vincristine—muscle cancer	0.000658	0.0043	CcSEcCtD
Nisoldipine—Colitis—Doxorubicin—muscle cancer	0.000657	0.0043	CcSEcCtD
Nisoldipine—Oedema—Dactinomycin—muscle cancer	0.00065	0.00425	CcSEcCtD
Nisoldipine—Blood urea increased—Doxorubicin—muscle cancer	0.000646	0.00422	CcSEcCtD
Nisoldipine—Vaginal infection—Doxorubicin—muscle cancer	0.000646	0.00422	CcSEcCtD
Nisoldipine—Vertigo—Vincristine—muscle cancer	0.00064	0.00418	CcSEcCtD
Nisoldipine—Leukopenia—Vincristine—muscle cancer	0.000637	0.00417	CcSEcCtD
Nisoldipine—Cramps of lower extremities—Doxorubicin—muscle cancer	0.000629	0.00411	CcSEcCtD
Nisoldipine—Rash maculo-papular—Doxorubicin—muscle cancer	0.000622	0.00407	CcSEcCtD
Nisoldipine—Anorexia—Dactinomycin—muscle cancer	0.00062	0.00405	CcSEcCtD
Nisoldipine—Mouth ulceration—Doxorubicin—muscle cancer	0.000619	0.00404	CcSEcCtD
Nisoldipine—Ecchymosis—Doxorubicin—muscle cancer	0.000619	0.00404	CcSEcCtD
Nisoldipine—Dermatitis exfoliative—Methotrexate—muscle cancer	0.000608	0.00397	CcSEcCtD
Nisoldipine—Myalgia—Vincristine—muscle cancer	0.000606	0.00396	CcSEcCtD
Nisoldipine—Hypertonia—Doxorubicin—muscle cancer	0.0006	0.00392	CcSEcCtD
Nisoldipine—Abnormal vision—Doxorubicin—muscle cancer	0.000597	0.0039	CcSEcCtD
Nisoldipine—Chills—Etoposide—muscle cancer	0.000595	0.00389	CcSEcCtD
Nisoldipine—Mental disability—Doxorubicin—muscle cancer	0.000594	0.00388	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000593	0.00387	CcSEcCtD
Nisoldipine—Alopecia—Etoposide—muscle cancer	0.000586	0.00383	CcSEcCtD
Nisoldipine—Cerebrovascular accident—Methotrexate—muscle cancer	0.000585	0.00383	CcSEcCtD
Nisoldipine—Oedema—Vincristine—muscle cancer	0.000581	0.0038	CcSEcCtD
Nisoldipine—Diabetes mellitus—Doxorubicin—muscle cancer	0.000571	0.00373	CcSEcCtD
Nisoldipine—Decreased appetite—Dactinomycin—muscle cancer	0.000565	0.0037	CcSEcCtD
Nisoldipine—Dysgeusia—Etoposide—muscle cancer	0.000565	0.00369	CcSEcCtD
Nisoldipine—Hyperhidrosis—Vincristine—muscle cancer	0.000562	0.00367	CcSEcCtD
Nisoldipine—Muscle spasms—Etoposide—muscle cancer	0.000555	0.00363	CcSEcCtD
Nisoldipine—Anorexia—Vincristine—muscle cancer	0.000554	0.00362	CcSEcCtD
Nisoldipine—Cardiac failure congestive—Doxorubicin—muscle cancer	0.000548	0.00358	CcSEcCtD
Nisoldipine—Hypotension—Vincristine—muscle cancer	0.000543	0.00355	CcSEcCtD
Nisoldipine—Ataxia—Methotrexate—muscle cancer	0.000539	0.00353	CcSEcCtD
Nisoldipine—Feeling abnormal—Dactinomycin—muscle cancer	0.000536	0.0035	CcSEcCtD
Nisoldipine—Ill-defined disorder—Etoposide—muscle cancer	0.000535	0.0035	CcSEcCtD
Nisoldipine—Anaemia—Etoposide—muscle cancer	0.000533	0.00349	CcSEcCtD
Nisoldipine—Liver function test abnormal—Methotrexate—muscle cancer	0.00053	0.00346	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000529	0.00346	CcSEcCtD
Nisoldipine—Increased appetite—Doxorubicin—muscle cancer	0.000529	0.00346	CcSEcCtD
Nisoldipine—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000526	0.00344	CcSEcCtD
Nisoldipine—Insomnia—Vincristine—muscle cancer	0.000526	0.00344	CcSEcCtD
Nisoldipine—Paraesthesia—Vincristine—muscle cancer	0.000522	0.00341	CcSEcCtD
Nisoldipine—Malaise—Etoposide—muscle cancer	0.00052	0.0034	CcSEcCtD
Nisoldipine—Vertigo—Etoposide—muscle cancer	0.000518	0.00339	CcSEcCtD
Nisoldipine—Leukopenia—Etoposide—muscle cancer	0.000516	0.00338	CcSEcCtD
Nisoldipine—Body temperature increased—Dactinomycin—muscle cancer	0.000514	0.00336	CcSEcCtD
Nisoldipine—Loss of consciousness—Etoposide—muscle cancer	0.000507	0.00331	CcSEcCtD
Nisoldipine—Cerebrovascular accident—Doxorubicin—muscle cancer	0.000507	0.00331	CcSEcCtD
Nisoldipine—Decreased appetite—Vincristine—muscle cancer	0.000505	0.0033	CcSEcCtD
Nisoldipine—Cough—Etoposide—muscle cancer	0.000503	0.00329	CcSEcCtD
Nisoldipine—ABCB1—bone marrow—muscle cancer	0.000503	0.00484	CbGeAlD
Nisoldipine—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.000497	0.00325	CcSEcCtD
Nisoldipine—Asthma—Methotrexate—muscle cancer	0.000496	0.00324	CcSEcCtD
Nisoldipine—Chest pain—Etoposide—muscle cancer	0.000491	0.00321	CcSEcCtD
Nisoldipine—Migraine—Doxorubicin—muscle cancer	0.000489	0.0032	CcSEcCtD
Nisoldipine—Discomfort—Etoposide—muscle cancer	0.000485	0.00317	CcSEcCtD
Nisoldipine—ABCB1—vagina—muscle cancer	0.000482	0.00464	CbGeAlD
Nisoldipine—Face oedema—Doxorubicin—muscle cancer	0.00048	0.00314	CcSEcCtD
Nisoldipine—Hypersensitivity—Dactinomycin—muscle cancer	0.000479	0.00313	CcSEcCtD
Nisoldipine—Confusional state—Etoposide—muscle cancer	0.000475	0.0031	CcSEcCtD
Nisoldipine—Ataxia—Doxorubicin—muscle cancer	0.000467	0.00305	CcSEcCtD
Nisoldipine—Dysuria—Methotrexate—muscle cancer	0.000464	0.00303	CcSEcCtD
Nisoldipine—Tachycardia—Etoposide—muscle cancer	0.000459	0.003	CcSEcCtD
Nisoldipine—Body temperature increased—Vincristine—muscle cancer	0.000459	0.003	CcSEcCtD
Nisoldipine—Liver function test abnormal—Doxorubicin—muscle cancer	0.000459	0.003	CcSEcCtD
Nisoldipine—Erectile dysfunction—Methotrexate—muscle cancer	0.000457	0.00299	CcSEcCtD
Nisoldipine—Dry skin—Doxorubicin—muscle cancer	0.000455	0.00298	CcSEcCtD
Nisoldipine—Hyperhidrosis—Etoposide—muscle cancer	0.000455	0.00297	CcSEcCtD
Nisoldipine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000454	0.00297	CcSEcCtD
Nisoldipine—Hypokalaemia—Doxorubicin—muscle cancer	0.000452	0.00296	CcSEcCtD
Nisoldipine—Anorexia—Etoposide—muscle cancer	0.000449	0.00293	CcSEcCtD
Nisoldipine—Diarrhoea—Dactinomycin—muscle cancer	0.000445	0.00291	CcSEcCtD
Nisoldipine—ABCB1—head—muscle cancer	0.000445	0.00428	CbGeAlD
Nisoldipine—Hypotension—Etoposide—muscle cancer	0.00044	0.00288	CcSEcCtD
Nisoldipine—Gastritis—Doxorubicin—muscle cancer	0.00044	0.00287	CcSEcCtD
Nisoldipine—Muscular weakness—Doxorubicin—muscle cancer	0.000438	0.00286	CcSEcCtD
Nisoldipine—Stomatitis—Methotrexate—muscle cancer	0.000431	0.00282	CcSEcCtD
Nisoldipine—Conjunctivitis—Methotrexate—muscle cancer	0.00043	0.00281	CcSEcCtD
Nisoldipine—ABCB1—testis—muscle cancer	0.00043	0.00414	CbGeAlD
Nisoldipine—Asthma—Doxorubicin—muscle cancer	0.000429	0.00281	CcSEcCtD
Nisoldipine—Influenza—Doxorubicin—muscle cancer	0.000429	0.00281	CcSEcCtD
Nisoldipine—Dysphagia—Doxorubicin—muscle cancer	0.000429	0.00281	CcSEcCtD
Nisoldipine—Hypersensitivity—Vincristine—muscle cancer	0.000428	0.0028	CcSEcCtD
Nisoldipine—Sweating—Methotrexate—muscle cancer	0.000424	0.00277	CcSEcCtD
Nisoldipine—Paraesthesia—Etoposide—muscle cancer	0.000423	0.00276	CcSEcCtD
Nisoldipine—Haematuria—Methotrexate—muscle cancer	0.000422	0.00276	CcSEcCtD
Nisoldipine—Dyspnoea—Etoposide—muscle cancer	0.00042	0.00274	CcSEcCtD
Nisoldipine—Somnolence—Etoposide—muscle cancer	0.000419	0.00274	CcSEcCtD
Nisoldipine—Epistaxis—Methotrexate—muscle cancer	0.000417	0.00273	CcSEcCtD
Nisoldipine—Rash—Dactinomycin—muscle cancer	0.00041	0.00268	CcSEcCtD
Nisoldipine—Decreased appetite—Etoposide—muscle cancer	0.000409	0.00268	CcSEcCtD
Nisoldipine—Dysuria—Doxorubicin—muscle cancer	0.000401	0.00262	CcSEcCtD
Nisoldipine—Diarrhoea—Vincristine—muscle cancer	0.000398	0.0026	CcSEcCtD
Nisoldipine—Pollakiuria—Doxorubicin—muscle cancer	0.000397	0.00259	CcSEcCtD
Nisoldipine—Pharyngitis—Methotrexate—muscle cancer	0.000394	0.00258	CcSEcCtD
Nisoldipine—Weight increased—Doxorubicin—muscle cancer	0.000391	0.00255	CcSEcCtD
Nisoldipine—Weight decreased—Doxorubicin—muscle cancer	0.000388	0.00254	CcSEcCtD
Nisoldipine—Feeling abnormal—Etoposide—muscle cancer	0.000388	0.00254	CcSEcCtD
Nisoldipine—Nausea—Dactinomycin—muscle cancer	0.000386	0.00253	CcSEcCtD
Nisoldipine—Dizziness—Vincristine—muscle cancer	0.000384	0.00251	CcSEcCtD
Nisoldipine—Visual impairment—Methotrexate—muscle cancer	0.000382	0.0025	CcSEcCtD
Nisoldipine—Urticaria—Etoposide—muscle cancer	0.000374	0.00244	CcSEcCtD
Nisoldipine—Stomatitis—Doxorubicin—muscle cancer	0.000373	0.00244	CcSEcCtD
Nisoldipine—Body temperature increased—Etoposide—muscle cancer	0.000372	0.00243	CcSEcCtD
Nisoldipine—Conjunctivitis—Doxorubicin—muscle cancer	0.000372	0.00243	CcSEcCtD
Nisoldipine—Tinnitus—Methotrexate—muscle cancer	0.00037	0.00242	CcSEcCtD
Nisoldipine—Sweating—Doxorubicin—muscle cancer	0.000367	0.0024	CcSEcCtD
Nisoldipine—Rash—Vincristine—muscle cancer	0.000366	0.0024	CcSEcCtD
Nisoldipine—Dermatitis—Vincristine—muscle cancer	0.000366	0.00239	CcSEcCtD
Nisoldipine—Haematuria—Doxorubicin—muscle cancer	0.000365	0.00239	CcSEcCtD
Nisoldipine—Headache—Vincristine—muscle cancer	0.000364	0.00238	CcSEcCtD
Nisoldipine—Epistaxis—Doxorubicin—muscle cancer	0.000361	0.00236	CcSEcCtD
Nisoldipine—Sinusitis—Doxorubicin—muscle cancer	0.000359	0.00235	CcSEcCtD
Nisoldipine—Chills—Methotrexate—muscle cancer	0.000356	0.00233	CcSEcCtD
Nisoldipine—Alopecia—Methotrexate—muscle cancer	0.000351	0.00229	CcSEcCtD
Nisoldipine—Hypersensitivity—Etoposide—muscle cancer	0.000347	0.00227	CcSEcCtD
Nisoldipine—Nausea—Vincristine—muscle cancer	0.000345	0.00226	CcSEcCtD
Nisoldipine—Rhinitis—Doxorubicin—muscle cancer	0.000345	0.00225	CcSEcCtD
Nisoldipine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000342	0.00224	CcSEcCtD
Nisoldipine—Pharyngitis—Doxorubicin—muscle cancer	0.000341	0.00223	CcSEcCtD
Nisoldipine—Oedema peripheral—Doxorubicin—muscle cancer	0.000339	0.00221	CcSEcCtD
Nisoldipine—Dysgeusia—Methotrexate—muscle cancer	0.000338	0.00221	CcSEcCtD
Nisoldipine—Pruritus—Etoposide—muscle cancer	0.000333	0.00218	CcSEcCtD
Nisoldipine—Visual impairment—Doxorubicin—muscle cancer	0.000331	0.00217	CcSEcCtD
Nisoldipine—Diarrhoea—Etoposide—muscle cancer	0.000322	0.00211	CcSEcCtD
Nisoldipine—Ill-defined disorder—Methotrexate—muscle cancer	0.000321	0.0021	CcSEcCtD
Nisoldipine—Tinnitus—Doxorubicin—muscle cancer	0.00032	0.00209	CcSEcCtD
Nisoldipine—Anaemia—Methotrexate—muscle cancer	0.000319	0.00209	CcSEcCtD
Nisoldipine—Malaise—Methotrexate—muscle cancer	0.000312	0.00204	CcSEcCtD
Nisoldipine—Dizziness—Etoposide—muscle cancer	0.000311	0.00204	CcSEcCtD
Nisoldipine—Vertigo—Methotrexate—muscle cancer	0.00031	0.00203	CcSEcCtD
Nisoldipine—Leukopenia—Methotrexate—muscle cancer	0.000309	0.00202	CcSEcCtD
Nisoldipine—Chills—Doxorubicin—muscle cancer	0.000308	0.00202	CcSEcCtD
Nisoldipine—Alopecia—Doxorubicin—muscle cancer	0.000304	0.00199	CcSEcCtD
Nisoldipine—Cough—Methotrexate—muscle cancer	0.000301	0.00197	CcSEcCtD
Nisoldipine—Rash—Etoposide—muscle cancer	0.000297	0.00194	CcSEcCtD
Nisoldipine—Dermatitis—Etoposide—muscle cancer	0.000297	0.00194	CcSEcCtD
Nisoldipine—Headache—Etoposide—muscle cancer	0.000295	0.00193	CcSEcCtD
Nisoldipine—Flatulence—Doxorubicin—muscle cancer	0.000295	0.00193	CcSEcCtD
Nisoldipine—Chest pain—Methotrexate—muscle cancer	0.000294	0.00192	CcSEcCtD
Nisoldipine—Arthralgia—Methotrexate—muscle cancer	0.000294	0.00192	CcSEcCtD
Nisoldipine—Myalgia—Methotrexate—muscle cancer	0.000294	0.00192	CcSEcCtD
Nisoldipine—Tension—Doxorubicin—muscle cancer	0.000294	0.00192	CcSEcCtD
Nisoldipine—Dysgeusia—Doxorubicin—muscle cancer	0.000293	0.00192	CcSEcCtD
Nisoldipine—Discomfort—Methotrexate—muscle cancer	0.000291	0.0019	CcSEcCtD
Nisoldipine—Nervousness—Doxorubicin—muscle cancer	0.000291	0.0019	CcSEcCtD
Nisoldipine—Muscle spasms—Doxorubicin—muscle cancer	0.000288	0.00188	CcSEcCtD
Nisoldipine—Confusional state—Methotrexate—muscle cancer	0.000284	0.00186	CcSEcCtD
Nisoldipine—Nausea—Etoposide—muscle cancer	0.00028	0.00183	CcSEcCtD
Nisoldipine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000278	0.00181	CcSEcCtD
Nisoldipine—Anaemia—Doxorubicin—muscle cancer	0.000277	0.00181	CcSEcCtD
Nisoldipine—Hyperhidrosis—Methotrexate—muscle cancer	0.000273	0.00178	CcSEcCtD
Nisoldipine—Malaise—Doxorubicin—muscle cancer	0.00027	0.00176	CcSEcCtD
Nisoldipine—Vertigo—Doxorubicin—muscle cancer	0.000269	0.00176	CcSEcCtD
Nisoldipine—Anorexia—Methotrexate—muscle cancer	0.000269	0.00176	CcSEcCtD
Nisoldipine—Syncope—Doxorubicin—muscle cancer	0.000268	0.00175	CcSEcCtD
Nisoldipine—Leukopenia—Doxorubicin—muscle cancer	0.000268	0.00175	CcSEcCtD
Nisoldipine—Palpitations—Doxorubicin—muscle cancer	0.000264	0.00173	CcSEcCtD
Nisoldipine—Hypotension—Methotrexate—muscle cancer	0.000263	0.00172	CcSEcCtD
Nisoldipine—Loss of consciousness—Doxorubicin—muscle cancer	0.000263	0.00172	CcSEcCtD
Nisoldipine—Cough—Doxorubicin—muscle cancer	0.000261	0.00171	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000257	0.00168	CcSEcCtD
Nisoldipine—Insomnia—Methotrexate—muscle cancer	0.000255	0.00167	CcSEcCtD
Nisoldipine—Arthralgia—Doxorubicin—muscle cancer	0.000255	0.00167	CcSEcCtD
Nisoldipine—Chest pain—Doxorubicin—muscle cancer	0.000255	0.00167	CcSEcCtD
Nisoldipine—Myalgia—Doxorubicin—muscle cancer	0.000255	0.00167	CcSEcCtD
Nisoldipine—Anxiety—Doxorubicin—muscle cancer	0.000254	0.00166	CcSEcCtD
Nisoldipine—Paraesthesia—Methotrexate—muscle cancer	0.000253	0.00166	CcSEcCtD
Nisoldipine—Discomfort—Doxorubicin—muscle cancer	0.000252	0.00165	CcSEcCtD
Nisoldipine—Dyspnoea—Methotrexate—muscle cancer	0.000251	0.00164	CcSEcCtD
Nisoldipine—Somnolence—Methotrexate—muscle cancer	0.000251	0.00164	CcSEcCtD
Nisoldipine—Dry mouth—Doxorubicin—muscle cancer	0.000249	0.00163	CcSEcCtD
Nisoldipine—Dyspepsia—Methotrexate—muscle cancer	0.000248	0.00162	CcSEcCtD
Nisoldipine—Confusional state—Doxorubicin—muscle cancer	0.000246	0.00161	CcSEcCtD
Nisoldipine—Decreased appetite—Methotrexate—muscle cancer	0.000245	0.0016	CcSEcCtD
Nisoldipine—Oedema—Doxorubicin—muscle cancer	0.000244	0.0016	CcSEcCtD
Nisoldipine—Shock—Doxorubicin—muscle cancer	0.00024	0.00157	CcSEcCtD
Nisoldipine—Tachycardia—Doxorubicin—muscle cancer	0.000238	0.00156	CcSEcCtD
Nisoldipine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000236	0.00154	CcSEcCtD
Nisoldipine—Anorexia—Doxorubicin—muscle cancer	0.000233	0.00152	CcSEcCtD
Nisoldipine—Feeling abnormal—Methotrexate—muscle cancer	0.000232	0.00152	CcSEcCtD
Nisoldipine—Hypotension—Doxorubicin—muscle cancer	0.000228	0.00149	CcSEcCtD
Nisoldipine—Urticaria—Methotrexate—muscle cancer	0.000224	0.00146	CcSEcCtD
Nisoldipine—Body temperature increased—Methotrexate—muscle cancer	0.000223	0.00146	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000222	0.00145	CcSEcCtD
Nisoldipine—Insomnia—Doxorubicin—muscle cancer	0.000221	0.00144	CcSEcCtD
Nisoldipine—Paraesthesia—Doxorubicin—muscle cancer	0.000219	0.00143	CcSEcCtD
Nisoldipine—Dyspnoea—Doxorubicin—muscle cancer	0.000218	0.00142	CcSEcCtD
Nisoldipine—Somnolence—Doxorubicin—muscle cancer	0.000217	0.00142	CcSEcCtD
Nisoldipine—Dyspepsia—Doxorubicin—muscle cancer	0.000215	0.00141	CcSEcCtD
Nisoldipine—Decreased appetite—Doxorubicin—muscle cancer	0.000212	0.00139	CcSEcCtD
Nisoldipine—Hypersensitivity—Methotrexate—muscle cancer	0.000208	0.00136	CcSEcCtD
Nisoldipine—Feeling abnormal—Doxorubicin—muscle cancer	0.000201	0.00132	CcSEcCtD
Nisoldipine—Pruritus—Methotrexate—muscle cancer	0.000199	0.0013	CcSEcCtD
Nisoldipine—Urticaria—Doxorubicin—muscle cancer	0.000194	0.00127	CcSEcCtD
Nisoldipine—Body temperature increased—Doxorubicin—muscle cancer	0.000193	0.00126	CcSEcCtD
Nisoldipine—Diarrhoea—Methotrexate—muscle cancer	0.000193	0.00126	CcSEcCtD
Nisoldipine—Dizziness—Methotrexate—muscle cancer	0.000186	0.00122	CcSEcCtD
Nisoldipine—Hypersensitivity—Doxorubicin—muscle cancer	0.00018	0.00118	CcSEcCtD
Nisoldipine—Rash—Methotrexate—muscle cancer	0.000178	0.00116	CcSEcCtD
Nisoldipine—Dermatitis—Methotrexate—muscle cancer	0.000178	0.00116	CcSEcCtD
Nisoldipine—Headache—Methotrexate—muscle cancer	0.000177	0.00115	CcSEcCtD
Nisoldipine—Pruritus—Doxorubicin—muscle cancer	0.000173	0.00113	CcSEcCtD
Nisoldipine—Nausea—Methotrexate—muscle cancer	0.000167	0.00109	CcSEcCtD
Nisoldipine—Diarrhoea—Doxorubicin—muscle cancer	0.000167	0.00109	CcSEcCtD
Nisoldipine—Dizziness—Doxorubicin—muscle cancer	0.000161	0.00106	CcSEcCtD
Nisoldipine—Rash—Doxorubicin—muscle cancer	0.000154	0.00101	CcSEcCtD
Nisoldipine—Dermatitis—Doxorubicin—muscle cancer	0.000154	0.00101	CcSEcCtD
Nisoldipine—Headache—Doxorubicin—muscle cancer	0.000153	0.001	CcSEcCtD
Nisoldipine—Nausea—Doxorubicin—muscle cancer	0.000145	0.000948	CcSEcCtD
